Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,757,908
-
Total 13F shares
-
29,478,109
-
Share change
-
+471,474
-
Total reported value
-
$207,757,723
-
Price per share
-
$7.05
-
Number of holders
-
100
-
Value change
-
+$3,376,858
-
Number of buys
-
40
-
Number of sells
-
42
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2021
As of 31 Dec 2021,
HARVARD BIOSCIENCE INC - Common Stock (HBIO) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,478,109 shares.
The largest 10 holders included
BlackRock Inc., Portolan Capital Management, LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., DIMENSIONAL FUND ADVISORS LP, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, Granahan Investment Management, LLC, Harvey Partners, LLC, ACADIAN ASSET MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
100
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.